Interferon responsiveness (represented by the case number of complete responders/non-responders) in three different viral types (W, J, and genotype 2a) by univariate analysis according to clinical, histological, and virological variants
| Sex | Male (n=80) | Female (n=41) | Odds ratio | 95% CI | p Value |
| W type | 4/23 | 6/8 | 0.23 | 0.055–0.983 | 0.047 |
| J type | 6/19 | 4/9 | 0.71 | 0.160–3.152 | 0.468 |
| 2a | 17/11 | 7/7 | 1.55 | 0.425–5.614 | 0.508 |
| Age (y) | <50 (n=56) | ⩾50 (n=65) | Odds ratio | 95% CI | p Value |
| W type | 6/17 | 4/14 | 1.24 | 0.290–5.257 | 0.775 |
| J type | 6/11 | 4/17 | 2.32 | 0.540–9.954 | 0.258 |
| 2a | 10/6 | 14/12 | 1.43 | 0.401–5.088 | 0.582 |
| Transfusion history | Yes (n=43) | No (n=78) | Odds ratio | 95% CI | p Value |
| W type | 5/15 | 5/16 | 1.07 | 0.256–4.438 | 0.929 |
| J type | 8/10 | 2/18 | 7.20 | 1.443–35.914 | 0.016 |
| 2a | 3/2 | 21/16 | 1.14 | 0.170–7.662 | 0.891 |
| Grading score3-150 | 1–8 (n=65) | 9–18 (n=56) | Odds ratio | 95% CI | p Value |
| W type | 4/9 | 6/22 | 1.63 | 0.372–7.137 | 0.517 |
| J type | 4/19 | 6/9 | 0.32 | 0.073–1.360 | 0.122 |
| 2a | 17/12 | 7/6 | 1.21 | 0.326–4.530 | 0.773 |
| Staging score3-160 | 0–1 (n=70) | 2–4 (n=51) | Odds ratio | 95% CI | p Value |
| W type | 5/15 | 5/16 | 1.07 | 0.256–4.438 | 0.929 |
| J type | 5/17 | 5/11 | 0.65 | 0.152–2.754 | 0.556 |
| 2a | 16/12 | 8/6 | 1.00 | 1.000 | |
| HCV RNA (×106eq/ml) | <1.0 (n=56) | ⩾1.0 (n=65) | Odds ratio | 95% CI | p Value |
| W type | 9/3 | 1/28 | 84.00 | 14.039–502.613 | <0.0001 |
| J type | 9/2 | 1/26 | 117.00 | 17.817–768.332 | <0.0001 |
| 2a | 23/10 | 1/8 | 18.40 | 3.002–112.789 | 0.0016 |
| ISDR | Wild-type (n=40) | Mutant-type (n=39) | Odds ratio | 95% CI | p Value |
| W type | 4/19 | 6/12 | 0.42 | 0.100–1.772 | 0.238 |
| J type | 1/16 | 9/12 | 0.08 | 0.013–0.553 | 0.010 |